Thyroid stimulating hormone receptor antibodies, also known as TRAb, can stimulate the thyroid gland and is the pathogeny of Graves’ disease.[1] The main treatment options for Graves’ disease include antithyroid drugs (ATDs) and radioactive iodine.[2] In some regions, ATDs are the first choice. Here, TSHR is linked to Graves disease.